| Trial ID: | L6390 |
| Source ID: | NCT00241085
|
| Associated Drug: |
Valsartan
|
| Title: |
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
PROTEINURIA|Hypertension|Type 2 Diabetes
|
| Interventions: |
DRUG: valsartan
|
| Outcome Measures: |
Primary: Change from baseline in urinary protein excretion after 30 weeks | Secondary: Change from baseline in circulating markers of blood vessel inflammation, insulin resistance, serum creatinine, diabetic control, and proportion of patients who return to normalization of protein excretion after 30 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
392
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-11
|
| Completion Date: |
2005-08
|
| Results First Posted: |
|
| Last Update Posted: |
2011-11-08
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00241085
|
